160
Views
17
CrossRef citations to date
0
Altmetric
Original Research

The Efficacy of N-Butylphthalide and Dexamethasone Combined with Hyperbaric Oxygen on Delayed Encephalopathy After Acute Carbon Monoxide Poisoning

ORCID Icon, , , & ORCID Icon
Pages 1333-1339 | Published online: 02 Apr 2020

References

  • Centers for disease control and prevention(CDC). Carbon monoxide exposures-United States, 2000–2009. MMWR. 2011;60(30):1014–1017.21814164
  • KalayN, OzdogruI, CetinkayaY, et al. Cardiovascular effects of carbon monoxide poisoning. Am J Cardiol. 2007;99(3):322–324. doi:10.1016/j.amjcard.2006.08.03017261390
  • GeraldoAF, SilvaC, NeutelD, NetoLL, AlbuquerqueL. Delayed leukoencephalopathy after acute carbon monoxide intoxication. J Radiol Case Rep. 2014;8(5):1–8. doi:10.3941/jrcr.v8i5.1721
  • GoldsteinM. Carbon monoxide Poisoning. J Emerg Nurs. 2008;34(6):538–542. doi:10.1016/j.jen.2007.11.01419022078
  • GillTM, GahbauerEA, HanL, et al. Trajectories of disability in the last year of life. N Engl J Med. 2010;362(13):1173–1180. doi:10.1056/NEJMoa090908720357280
  • MitchellSL, TenoJM, KielyDK, et al. The clinical course of advanced dementia. N Engl J Med. 2009;361(16):1529–1538. doi:10.1056/NEJMoa090223419828530
  • ThomSR, BhopaleVM, FisherD, et al. Delayed neuropathology after carbon monoxide poisoning is immune-mediated. Proc Natl Acad Sci USA. 2004;101(37):13660–13665. doi:10.1073/pnas.040564210115342916
  • ThomSR, BhopaleVM, FisherD, ZhangJ, GimottyP. Delayed neuropathology after carbon monoxide poisoning is immune-mediated. Proc Natl Acad Sci USA. 2004;101(37):13660–13665. doi:10.1073/pnas.040564210115342916
  • GuzmanJA. carbon monoxide poisoning. Crit Care Clin. 2012;28(4):537–548. doi:10.1016/j.ccc.2012.07.00722998990
  • WeaverLK, HopkinsRO, ChanKJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med. 2002;347(14):1057–1067. doi:10.1056/NEJMoa01312112362006
  • AnnaneD, ChaddaK, GajdosP, et al. Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trials. Intensive Care Med. 2011;37(3):486–492. doi:10.1007/s00134-010-2093-021125215
  • WeaverLK, ValentineKJ, HopkinsRO. Carbon monoxide poisoning: risk factors for cognitive sequelae and the role of hyperbaric oxygen. Am J Respir Crit Care Med. 2007;176(5):491–497. doi:10.1164/rccm.200701-026OC17496229
  • WeaverLK. Hyperbaric oxygen therapy for carbon monoxide poisoning. Undersea Hyperb Med. 2014;41(4):339–354.25109087
  • MaoM, RaoP, MouX, et al. Clinical observation on delayed encephalopathy after carbon monoxide poisoning treated with acupuncture to restore consciousness combined with hyperbaric oxygen treatment. Zhongguo Zhen Jiu. 2015;35(3):213–216.26062182
  • DiaoXX, ZhongK, XLL, et al. Isomer-selective distribution of 3-nbutylphthalide (NBP) hydroxylated metabolites, 3-hydroxy-NBP and 10-hydroxy-NBP, across the rat blood-brain barrier. Acta Pharmacol Sin. 2015;36(12):1520–1527. doi:10.1038/aps.2015.6426567730
  • PengY, XingC, XuS, et al. L-3-n-butylphthalide improves cognitive impairment induced by intracerebroventricular infusion of amyloid-β peptide in rats. Eur J Pharmacol. 2009;621(1–3):38–45. doi:10.1016/j.ejphar.2009.08.03619737553
  • XuJ, HuaiY, MengN, et al. L-3-n-Butylphthalide activates Akt/mTOR signaling, inhibits neuronal apoptosis and autophagy and improves cognitive impairment in mice with repeated cerebral ischemia-reperfusion injury. Neurochem Res. 2017;42(10):2968–2981. doi:10.1007/s11064-017-2328-328620824
  • ZhaoY, LeeJH, ChenD, et al. DL-3-n-butylphthalide induced neuroprotection, regenerative repair, functional recovery and psychological benefits following traumatic brain injury in mice. Neurochem Int. 2017;111:82–92. doi:10.1016/j.neuint.2017.03.01728359729
  • AbdoulayeIA, GuoYJ. A review of recent advances in neuroprotective potential of 3-n-Butylphthalide and its derivatives. Biomed Res Int. 2016;2016:5012341. doi:10.1155/2016/501234128053983
  • ChenY, WuT, LiH, et al. Dl-3-n-Butylphthalide exerts dopaminergic neuroprotection through inhibition of neuroinflammation. Front Aging Neurosci. 2019;11:44.30873019
  • FitzpatrickT, GocanS, WangCQ, et al. How do neurologists diagnose transient ischemic attack: a systematic review. Int J Stroke. 2019;14(2):115–124. doi:10.1177/174749301881643030507363
  • LiF, MaQ, ZhaoH, et al. L-3-n-Butylphthalide reduces ischemic stroke injury and increases M2 microglial polarization. Metab Brain Dis. 2018;33(6):1995–2003. doi:10.1007/s11011-018-0307-230117100
  • YeX, RongZ, LiY, et al. Protective role of L-3-n-Butylphthalide in cognitive function and dysthymic disorders in mouse with chronic epilepsy. Front Pharmacol. 2018;9:734. doi:10.3389/fphar.2018.0073430050437
  • YinW, LanL, HuangZ, et al. Discovery of a ring-opened derivative of 3-n-butylphthalide bearing NO/H2S-donating moieties as a potential anti-ischemic stroke agent. Eur J Med Chem. 2016;115:369–380. doi:10.1016/j.ejmech.2016.03.04427031213
  • ZhouPT, WangLP, QuMJ, et al. Dl-3-N-butylphthalide promotes angiogenesis and upregulates sonic hedgehog expression after cerebral ischemia in rats. CNS Neurosci Ther. 2019;25(6):748–758. doi:10.1111/cns.2019.25.issue-630784219
  • WangL, WangX, LiT, ZhangY, JiH. 8e protects against acute cerebral ischemia by inhibition of PI3K gamma-mediated superoxide generation in microglia. Molecules. 2018;23:11.
  • PengY, SunJ, HonS, et al. Lemere, L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-β in a transgenic model of alzheimer’s disease. J Neurosci. 2010;30(24):8180–8189. doi:10.1523/JNEUROSCI.0340-10.201020554868
  • FengX, PengY, LiuM, CuiL. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis. Neuropharmacology. 2012;62(2):1004–1010. doi:10.1016/j.neuropharm.2011.10.00922056419
  • XiongN, HuangJ, ChenC, et al. Dl-3-n-butylphthalide, a natural antioxidant, protects dopamine neurons in rotenone models for Parkinson’s disease. Neurobiol Aging. 2012;33(8):1777–1791. doi:10.1016/j.neurobiolaging.2011.03.00721524431
  • LiQ, ChengY, BiM, et al. Effects of N-butylphthalide on the activation of Keap1/Nrf-2 signal pathway in rats after carbon monoxide poisoning. Environ Toxicol Pharmacol. 2015;40(1):22–29. doi:10.1016/j.etap.2015.05.00926056974
  • XiangW, XueH, WangB, et al. Efficacy of N-Butylphthalide and hyperbaric oxygen therapy on cognitive dysfunction in patients with delayed encephalopathy after acute carbon monoxide poisoning. Med Sci Monit. 2017;23:1501–1506. doi:10.12659/MSM.89949928352069
  • WangH, LiY, WuQ, XuC, LiuQ. Combination of butylphthalide with umbilical mesenchymal stem cells for the treatment of delayed encephalopathy after carbon monoxide poisoning. Medicine (Baltimore). 2016;95(49):e5412. doi:10.1097/MD.000000000000541227930518
  • XiangW, XueH, WangB, et al. Combined application of dexamethasone and hyperbaric oxygen therapy yields better efficacy for patients with delayed encephalopathy after acute carbon monoxide poisoning. Drug Des Devel Ther. 2017;11:513–519. doi:10.2147/DDDT.S126569
  • ShuAH, WangQ, ChenXB. Effect of different depths of anesthesia on postoperative cognitive function in laparoscopic patients: a randomized clinical trial. Curr Med Res Opin. 2015;31(10):1883–1887. doi:10.1185/03007995.2015.107596826202165
  • MaXY. Clinical study of large dose of dexamethasone combined with hyperbaric oxygen in treatment of acute carbon monoxide poisoning. Med Innov China. 2013;10(23):045–047.
  • BerlWG, HalpinB. Human fatalities from unwanted fires. Johns Hopkins University, applied physics laboratory, fire problems program. APL/JHW FPP. Baltimore, MD;1978.p.TR 37.
  • KimJH, ChangKH, SongIC, et al. Delayed encephalopathy of acute carbon monoxide intoxication: diffusivity of cerebral white matter lesions. AJNR Am J Neuroradiol. 2003;24(8):1592–1597.13679276
  • RaubJA, Mathieu-NolfM, HampsonNB, ThomSR. Carbon monoxide poisoning—a public health perspective. Toxicology. 2000;145(1):1–14. doi:10.1016/S0300-483X(99)00217-610771127
  • PenneyD, BenignusV, KephalopoulosS, KotziasD, KleinmanM, VerrierA. Carbon monoxide. In: WHO guidelines for indoor air quality: selected pollutants. 2010 Available from: http://www.ncbi.nlm.nih.gov/books/NBK138710/. Accessed 823, 2016
  • HampsonNB, PiantadosiCA, ThomSR, WeaverLK. Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning. Am J Respir Crit Care Med. 2012;186(11):1095–1101. doi:10.1164/rccm.201207-1284CI23087025
  • GormanD, DrewryA, HuangYL, SamesC. The clinical toxicology of carbon monoxide. Toxicol. 2003;187(1):25–38. doi:10.1016/S0300-483X(03)00005-2
  • NabeshimaT, KatohA, IshimH, et al. Carbon monoxide-induced delayed amnesia, delayed neuronal death and change in acetylcholine concentration in mice. Pharmacol Exp Ther. 1991;256:378–384.
  • LiQ, ChengY, BiMJ, et al. Effects of N-Butylphthalide on the expressions of Nogo/NgR in rat brain tissue after carbon monoxide poisoning. Environ Toxicol Pharmacol. 2015;39(2):953–961. doi:10.1016/j.etap.2015.02.01325812770
  • YangY, LiuY, WeiP, et al. Silencing Nogo-A promotes functional recovery in demyelinating disease. Ann Neurol. 2010;67(4):498–507. doi:10.1002/ana.2193520437585
  • IschiropoulosH, BeersMF, OhnishiST, et al. Nitric oxide production and perivascular nitration in brain after carbon monoxide poisoning in the rat. J Clin Invest. 1996;97(10):2260–2267. doi:10.1172/JCI1186678636405
  • WangM, SongJ, XiaoW, et al. Changes in lipid-sensitive two-pore domain potassium channel TREK-1 expression and its involvement in astrogliosis following cerebral ischemia in rats. J Mol Neurosci. 2012;46(2):384–392. doi:10.1007/s12031-011-9598-z21789545
  • AtalayH, AybekH, KoseogluM, et al. The effects of amifostine and dexamethasone on brain tissue lipid peroxidation during oxygen treatment of carbon monoxide-poisoned rats. Adv Ther. 2006;23(2):332–341. doi:10.1007/BF0285013816751165
  • LiQ, SongJJ, ZhangHY, FuK, LanHB, DengY. Dexamethasone therapy for preventing delayed encephalopathy after carbon monoxide poisoning. Biotech Histochem. 2015;90(8):561–567. doi:10.3109/10520295.2015.101956526052629